Comparıson Of Electromyography Results Before And After Vıtamın D Treatment In Patıents Wıth Carpal Tunnel Syndrome
1 other identifier
interventional
87
1 country
1
Brief Summary
Therefore, we aimed to evaluate the effectiveness of vitamin D replacement therapy on pain, electrophysiological parameters, ultrasonographic measurement results and functional status scales in CTS patients with low serum vitamin D levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Dec 2021
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2022
CompletedFirst Submitted
Initial submission to the registry
January 29, 2024
CompletedFirst Posted
Study publicly available on registry
February 28, 2024
CompletedFebruary 28, 2024
February 1, 2024
6 months
January 29, 2024
February 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
electrophysiological scale.
Electrophysiological Evaluation: Neurowerk (SIGMA-Medizin-TechnicGmbH/Germany) brand ENMG device was used. Patients were evaluated at room temperature of approximately 25 °C. All measurements were made by the same doctor. Our clinic's reference values for the diagnosis of CTS are shown below
at the baseline and immediately after treatment
Secondary Outcomes (1)
monofilament test
at the baseline and immediately after treatment
Other Outcomes (1)
Boston symptom severity scale
at the baseline and immediately after treatment
Study Arms (1)
Vitamin D in Carpal Tunnel Syndrome
EXPERIMENTALInterventions
Vitamin D replacement therapy was administered at 50,000 IU weekly for 8 weeks.
Eligibility Criteria
You may qualify if:
- years old male or female gender
- Those with mild to moderate CTS according to ENMG,
- Vitamin D level \<20.
You may not qualify if:
- Severe CTS according to ENMG
- Thenar region atrophy
- diabetes mellitus,
- rheumatoid arthritis,
- hyperthyroidism,
- hypothyroidism
- Traumatic nerve injury, history of surgery
- Polyneuropathy
- Pregnancy
- Severe psychiatric illness
- Poor orientation and cooperation,
- Injection (corticosteroid, ozone, stem cell…) applied for CTS treatment within 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr. Ayşe Güçlead
- Kayseri City Hospitalcollaborator
Study Sites (1)
Kayseri City Hospital
Kayseri, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- medical doctor
Study Record Dates
First Submitted
January 29, 2024
First Posted
February 28, 2024
Study Start
December 30, 2021
Primary Completion
June 30, 2022
Study Completion
August 30, 2022
Last Updated
February 28, 2024
Record last verified: 2024-02